Catalyst Wire Dossier Catalyst Wire Dossier

mFOLFOX7 (modified FOLFOX7) regimen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for mFOLFOX7 (modified FOLFOX7) regimen, covering 2024-09-23 to 2024-09-23. Get the full timeline:

Most recent: Clinical Trial Update: mFOLFOX7 Plus Camrelizumab and Apatinib in BCLC Stage A/B Hepatocellular Carcinoma Patients Beyond Milan Criteria [Phase 2]

See pricing